All News
Filter News
Found 808,966 articles
-
Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2023
11/8/2022
Beyond Air, Inc. announced financial results for its second fiscal quarter ended September 30, 2022.
-
AltruBio to Present at Stifel 2022 Healthcare Conference
11/8/2022
AltruBio Inc. announced that AltruBio President and Chief Executive Officer Judy Chou, Ph.D., and Chief Financial Officer Jeroen Grasman will present a corporate overview at the Stifel 2022 Healthcare Conference taking place November 15-16, 2022 in New York, NY.
-
Alkermes to Participate in the Stifel Healthcare Conference
11/8/2022
Alkermes plc announced that management will participate in a fireside chat at the Stifel 2022 Healthcare Conference on Tuesday, Nov. 15, 2022 at 8:00 a.m. ET.
-
JelloX Debut Highlights Potential to Disrupt Cancer Pathology
11/8/2022
JelloX Biotech's debut at Intel® Innovation in September drew the attention of healthcare experts and pharmaceutical brands alike for the Taiwan-based startup's potential to shape the future of cancer pathology using 3D imaging technology.
-
PepGen to Participate in the Stifel 2022 Healthcare Conference
11/8/2022
PepGen Inc. announced that James McArthur, Ph.D., President and CEO of PepGen will present at Stifel’s 2022 Annual Healthcare Conference in New York, New York on November 15th, 2022, at 9:45 A.M. ET.
-
Roivant Sciences Announces Pricing of Primary and Secondary Public Equity Offering
11/8/2022
Roivant Sciences Ltd. announced the pricing of its primary and secondary public offering of 30,000,000 common shares of Roivant, consisting of 20,000,000 common shares offered by Roivant and 10,000,000 common shares offered by the selling shareholders at a price to the public of $5.00 per share for total gross proceeds of $150 million, consisting of total gross proceeds to Roivant of approximately $100 million and total gross proceeds to the selling shareholders of approximately $50 million.
-
Kyocera AVX is Exhibiting at Electronica 2022
11/8/2022
KYOCERA AVX, a leading global manufacturer of advanced electronic components engineered to accelerate technological innovation and build a better future, is exhibiting at electronica 2022 in Munich, Germany, November 15–18.
-
Athenex to Participate in the 5th Annual Evercore ISI HealthCONx Conference
11/8/2022
Athenex announced that management will participate in the 5th Annual Evercore ISI HealthCONx Conference, taking place virtually November 29 to December 1, 2022.
-
Aadi Bioscience Announces Planned Leadership Transition - November 08, 2022
11/8/2022
Aadi Bioscience, Inc. announced the appointment of Neil Desai, Founder, President and CEO to Executive Chairman and Brendan Delaney, Chief Operating Officer, to President and CEO, effective as of January 1, 2023.
-
Deciphera Pharmaceuticals, Inc. to Participate in Upcoming November 2022 Investor Conferences
11/8/2022
Deciphera Pharmaceuticals, Inc. announced that members of the management team will participate in fireside chats at the following investor conferences.
-
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 21, 2022
11/8/2022
Aptorum Group Limited announced that it will hold its 2022 annual general meeting of shareholders at its London office located at 4T.07, 17 Hanover Square, Mayfair London, England W1S 1BN at 12:00 noon London Time on December 21, 2022.
-
Codexis to Participate in Upcoming Healthcare Conferences in November 2022
11/8/2022
Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, announced that management will participate in three upcoming investor conferences.
-
PMV Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Highlights
11/8/2022
PMV Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2022 and provided a corporate update.
-
Mersana Therapeutics to Present at 2022 Jefferies London Healthcare Conference
11/8/2022
Mersana Therapeutics, Inc. announced that members of management will present at the Jefferies London Healthcare Conference on Tuesday, November 15, 2022, at 3:50 p.m. GMT.
-
Salipro Biotech enters into collaboration and license agreement with Sanofi to advance discovery programs
11/8/2022
Swedish biotech company Salipro Biotech AB announced that it has entered into a research collaboration and license agreement with Sanofi on the discovery of therapeutic biologics against a challenging drug target.
-
Heska Corporation Reports Third Quarter 2022 Results
11/8/2022
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments for its third quarter ended September 30, 2022.
-
Atrion Reports Third Quarter 2022 Results
11/8/2022
Atrion Corporation announced its results for the third quarter ended September 30, 2022.
-
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
11/8/2022
ARS Pharmaceuticals, Inc. announced the closing of its merger with Silverback Therapeutics, Inc.
-
AquaBounty Technologies Announces Third Quarter 2022 Financial Results
11/8/2022
AquaBounty Technologies, Inc., a land-based aquaculture company utilizing technology to enhance productivity and sustainability, announced the Company’s financial results for the third quarter and nine-months ended September 30, 2022.
-
CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress
11/8/2022
CohBar, Inc. reported its financial results for the third quarter ended September 30, 2022 and highlighted recent corporate progress.